-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MAYH5v2hwf/dg2UHA7jxMpPN+qC9GQI39ZmVnfY1hLMzzA0W63/qbtp91QH5mMCR nQ+dwC/yJ7e9o1UzYDeH1Q== 0001230295-06-000090.txt : 20060404 0001230295-06-000090.hdr.sgml : 20060404 20060404142912 ACCESSION NUMBER: 0001230295-06-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060331 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THOMPSON VIRGIL CENTRAL INDEX KEY: 0001218821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 06737279 MAIL ADDRESS: STREET 1: 319 SOUTH NARDO CITY: SOIANA BEACH STATE: CA ZIP: 92075 4 1 tho47.xml X0202 4 2006-03-31 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218821 THOMPSON VIRGIL 755 BARBARA AVENUE SOLANA BEACH CA 92075 1 0 0 0 Common Stock, $.01 par value per share 2006-03-31 4 A 0 703 5.3300 A 29606.0000 D Option to Purchase Common Stock, $.01 par value 5.3300 2006-03-31 4 A 0 5000 5.3300 A 2007-03-31 2016-03-31 Common Stock, $.01 par value per share 5000.0000 5000.0000 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On March 31, 2006, the fair market value of the Common Stock, based on the closing price, was $5.33. These options will become fully vested and immediately exercisable on 3/31/2007. By: Beata A. Smith as Attorney-In-Fact for 2006-04-03 -----END PRIVACY-ENHANCED MESSAGE-----